$AYTU
Aytu Biopharma Inc

2015 Q3 Form 10-K Financial Statement

#000119312515333046 Filed on September 28, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 2014 Q2
Revenue $487.4K $261.8K $0.00
YoY Change 1666.98% 344.23%
Cost Of Revenue $37.33K $88.11K
YoY Change 16488.89%
Gross Profit $450.1K $173.7K
YoY Change 1545.08%
Gross Profit Margin 92.34% 66.34%
Selling, General & Admin $1.563M $3.981M $10.00K
YoY Change 38.18% 6534.96% 0.0%
% of Gross Profit 347.33% 2292.22%
Research & Development $855.9K $3.219M
YoY Change -8.34% -18.16%
% of Gross Profit 190.17% 1853.69%
Depreciation & Amortization $129.0K $118.2K $0.00
YoY Change 424.97% 21.26%
% of Gross Profit 28.67% 68.06%
Operating Expenses $2.650M $7.200M $10.00K
YoY Change 28.35% 83.05% 0.0%
Operating Profit -$2.163M -$7.632M
YoY Change 3.41% 20.25%
Interest Expense $113.3K $115.0K $0.00
YoY Change 203.61%
% of Operating Profit
Other Income/Expense, Net -$113.1K -$115.0K $0.00
YoY Change 203.27%
Pretax Income -$2.276M -$7.747M -$10.00K
YoY Change 6.91% 21.2% 0.0%
Income Tax $0.00 -$23.91K $0.00
% Of Pretax Income
Net Earnings -$2.276M -$7.723M -$10.00K
YoY Change 8.13% 38.44% 0.0%
Net Earnings / Revenue -467.02% -2950.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$7.662B -$40.26B -$1.350B
COMMON SHARES
Basic Shares Outstanding 14.26M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.10M $7.400M $0.00
YoY Change
Cash & Equivalents $10.07M $7.400M $2.640M
Short-Term Investments
Other Short-Term Assets $600.0K $500.0K $0.00
YoY Change
Inventory $494.1K $0.00
Prepaid Expenses $360.5K $521.3K
Receivables $167.9K $200.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.31M $8.000M $3.302M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $26.37K $0.00 $57.25K
YoY Change
Goodwill $74.00K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $300.0K $300.0K $0.00
YoY Change
Total Long-Term Assets $10.05M $10.20M $8.714M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $11.31M $8.000M $3.302M
Total Long-Term Assets $10.05M $10.20M $8.714M
Total Assets $21.36M $18.20M $12.02M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M $1.200M $649.5K
YoY Change
Accrued Expenses $600.0K $200.0K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.778M $1.500M $6.092M
YoY Change 1677.89% 1400.0% 5992.28%
LONG-TERM LIABILITIES
Long-Term Debt $4.800M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.300M $1.100M
YoY Change
Total Long-Term Liabilities $6.100M $1.100M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.778M $1.500M $6.092M
Total Long-Term Liabilities $6.100M $1.100M $0.00
Total Liabilities $7.951M $2.600M $6.647M
YoY Change 7850.85% 2500.0% 6546.69%
SHAREHOLDERS EQUITY
Retained Earnings -$20.66M -$10.66M
YoY Change
Common Stock $39.07M $16.03M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.41M $15.60M $5.369M
YoY Change
Total Liabilities & Shareholders Equity $21.36M $18.20M $12.02M
YoY Change

Cashflow Statement

Concept 2015 Q3 2015 2014 Q2
OPERATING ACTIVITIES
Net Income -$2.276M -$7.723M -$10.00K
YoY Change 8.13% 38.44% 0.0%
Depreciation, Depletion And Amortization $129.0K $118.2K $0.00
YoY Change 424.97% 21.26%
Cash From Operating Activities -$2.160M -$6.630M -$10.00K
YoY Change 21500.0% 16475.0% 0.0%
INVESTING ACTIVITIES
Capital Expenditures $3.554K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$1.000M
YoY Change
Cash From Investing Activities $0.00 -$1.000M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.880M 12.35M 30.00K
YoY Change 30775.0% 200.0%
NET CHANGE
Cash From Operating Activities -2.160M -6.630M -10.00K
Cash From Investing Activities 0.000 -1.000M 0.000
Cash From Financing Activities 4.880M 12.35M 30.00K
Net Change In Cash 2.720M 4.720M 20.00K
YoY Change -27300.0%
FREE CASH FLOW
Cash From Operating Activities -$2.160M -$6.630M -$10.00K
Capital Expenditures $3.554K $0.00 $0.00
Free Cash Flow -$2.164M -$6.630M -$10.00K
YoY Change 21535.54% 13348.82% 0.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
2391000
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14259681 shares
CY2014Q4 dei Entity Public Float
EntityPublicFloat
4349344
CY2012Q2 rswn Share Based Compensation Share Warrants Outstanding
ShareBasedCompensationShareWarrantsOutstanding
102613 shares
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
9811197
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2913700
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7901426 shares
CY2014Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
430000
CY2014Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
561059
CY2013Q2 rswn Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price
ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice
4.53
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
649503
CY2014Q2 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
0
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
85714
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
13000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10657937
CY2014Q2 us-gaap Liabilities
Liabilities
6646692
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12016099
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
1863000
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
511607
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
790
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
2779000
CY2014Q2 us-gaap Contractual Obligation
ContractualObligation
3222000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6092278
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
521322
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2639650
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7901426 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
433000
CY2014Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
24000
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16026554
CY2014Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
4600000
CY2014Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
150000
CY2014Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1427000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2014Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
466000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
5369407
CY2014Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
466000
CY2014Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
42807
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3847000
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
80000
CY2014Q2 us-gaap Assets
Assets
12016099
CY2014Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
190000
CY2014Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
8714247
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57246
CY2014Q2 us-gaap Deferred Tax Assets Gross Current
DeferredTaxAssetsGrossCurrent
32000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
3301852
CY2014Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10400000
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
699563
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
18897
CY2014Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
482000
CY2014Q2 rswn Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price
ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice
4.53
CY2014Q2 rswn Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
46002
CY2014Q2 rswn Share Based Compensation Share Warrants Outstanding
ShareBasedCompensationShareWarrantsOutstanding
102613 shares
CY2014Q2 rswn Indefinite Lived Intangible Asset In Process Research And Development
IndefiniteLivedIntangibleAssetInProcessResearchAndDevelopment
7500000
CY2014Q2 rswn Prepaid Research And Development Related Party
PrepaidResearchAndDevelopmentRelatedParty
121983
CY2014Q2 rswn Prepaid Research And Development Related Party Noncurrent
PrepaidResearchAndDevelopmentRelatedPartyNoncurrent
457438
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14259681 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1718828 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14259681 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38996367
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
15616452
CY2015Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
664000
CY2015Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1196817
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
85714
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
64000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18381341
CY2015Q2 us-gaap Liabilities
Liabilities
2610354
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18226806
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
4210000
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
425893
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
1426
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
2779000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1479034
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
41427
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
73000
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6337000
CY2015Q2 us-gaap Indefinite Lived Contractual Rights
IndefiniteLivedContractualRights
711000
CY2015Q2 us-gaap Assets
Assets
18226806
CY2015Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
158000
CY2015Q2 us-gaap Inventory Net
InventoryNet
39442
CY2015Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
10142947
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
313000
CY2013 rswn Class Of Warrant Or Rights Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm
P4Y4M28D
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5501962
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
157058
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29706
CY2015Q2 us-gaap Deferred Tax Assets Gross Current
DeferredTaxAssetsGrossCurrent
32000
CY2015Q2 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
5000000
CY2015Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
4886
CY2015Q2 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
79000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
8083859
CY2015Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
17100000
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
628776
CY2015Q2 us-gaap Goodwill
Goodwill
74000
CY2015Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
370888
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7353061
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
41427
CY2015Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
453000
CY2015Q2 rswn Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price
ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice
4.53
CY2015Q2 rswn Share Based Compensation Share Warrants Outstanding
ShareBasedCompensationShareWarrantsOutstanding
102613 shares
CY2015Q2 rswn Core And Developed Technology Net
CoreAndDevelopedTechnologyNet
780125
CY2015Q2 rswn Accrued Compensation Current
AccruedCompensationCurrent
196503
CY2015Q2 rswn Indefinite Lived Intangible Asset In Process Research And Development
IndefiniteLivedIntangibleAssetInProcessResearchAndDevelopment
7500000
CY2015Q2 rswn Number Of Stock Option Plans
NumberOfStockOptionPlans
2 Stock_Plan
CY2015Q2 rswn Prepaid Research And Development Related Party
PrepaidResearchAndDevelopmentRelatedParty
121983
CY2015Q2 rswn Prepaid Research And Development Related Party Noncurrent
PrepaidResearchAndDevelopmentRelatedPartyNoncurrent
335454
CY2015Q2 rswn Operating Leases Monthly Base Rent Initial Year
OperatingLeasesMonthlyBaseRentInitialYear
2900
CY2015Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
12.174 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0003 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0184 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2229 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0289 pure
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6949476 shares
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1273 pure
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9298
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-5578690
CY2014 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-6098374
CY2014 us-gaap Revenues
Revenues
58929
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
499690
CY2014 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-45553
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-6346834
CY2014 us-gaap Licenses Revenue
LicensesRevenue
58929
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
497322
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6392387
CY2014 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1736139
CY2014 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-6912071
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-813697
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
499690
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
191071
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4600000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
11000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-274050
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9298
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5237210
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3933619
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-813697
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2346557
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
46002
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
70000
CY2014 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
637210
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
421870
CY2014 us-gaap Depreciation
Depreciation
27000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
97476
CY2014 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
253000
CY2014 rswn Research And Development Related Party
ResearchAndDevelopmentRelatedParty
125587
CY2014 rswn Business Acquisitions Pro Forma Interest Income Expense Net
BusinessAcquisitionsProFormaInterestIncomeExpenseNet
-45553
CY2014 rswn Increase Decrease Accounts Payable Related Party Current
IncreaseDecreaseAccountsPayableRelatedPartyCurrent
561059
CY2014 rswn Business Acquisitions Pro Forma Operating Income Loss
BusinessAcquisitionsProFormaOperatingIncomeLoss
-6866518
CY2014 rswn Business Acquisitions Pro Forma Income Tax Expense Benefit
BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit
-813697
CY2014 rswn Amortization Of Prepaid Research And Development Due To Related Parties
AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties
35579
CY2014 rswn Increase Decrease In Prepaid Research And Development Due To Related Parties
IncreaseDecreaseInPrepaidResearchAndDevelopmentDueToRelatedParties
-465000
CY2014 rswn Issuance Of Common Stock In Exchange For Acquired Assets
IssuanceOfCommonStockInExchangeForAcquiredAssets
6803356
CY2014 rswn Prepaid Research And Development And Accrued Liability Related Parties Unpaid
PrepaidResearchAndDevelopmentAndAccruedLiabilityRelatedPartiesUnpaid
150000
CY2014 rswn Class Of Warrant Or Rights Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm
P3Y11M1D
CY2014 rswn Business Acquisitions Pro Forma Research And Development Expense
BusinessAcquisitionsProFormaResearchAndDevelopmentExpense
3933619
CY2014 rswn Business Acquisitions Pro Forma Research And Development Related Party
BusinessAcquisitionsProFormaResearchAndDevelopmentRelatedParty
125587
CY2014 rswn Business Acquisitions Pro Forma Cost Of Revenue
BusinessAcquisitionsProFormaCostOfRevenue
2054786
CY2014 rswn Business Acquisitions Pro Forma Amortization And Impairment Of Intangible Assets
BusinessAcquisitionsProFormaAmortizationAndImpairmentOfIntangibleAssets
100000
CY2014 rswn Business Acquisitions Proforma General And Administrative Expenses
BusinessAcquisitionsProformaGeneralAndAdministrativeExpenses
2388665
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6634214
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.815 pure
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001385818
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0003 pure
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0551 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3095 pure
CY2015 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On June 8, 2015, in connection with the reincorporation as a Delaware corporation, we effected a reverse stock split in which each common stock holder received one share of common stock for each every 12.174 shares then outstanding (the "Reverse Stock Split").
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0279 pure
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P37M
CY2015 dei Entity Registrant Name
EntityRegistrantName
AYTU BIOSCIENCE, INC.
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P10Y
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in accordance with Generally Accepted Accounting Principles in the United States of America (&#x201C;GAAP&#x201D;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions include valuation allowances, stock-based compensation, warrant valuation, purchase price allocation, valuation of contingent consideration, sales returns and allowances, useful lives of fixed assets and assumptions in evaluating impairment of definite and indefinite lived assets. Actual results could differ from these estimates.</p> </div>
CY2015 dei Trading Symbol
TradingSymbol
RSWN
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9207917 shares
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0030 pure
CY2015 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
27476
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-7723404
CY2015 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-8311155
CY2015 us-gaap Revenues
Revenues
261782
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1017938
CY2015 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-114994
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-7632320
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39442
CY2015 us-gaap Licenses Revenue
LicensesRevenue
85714
CY2015 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1000000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
157058
CY2015 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
664000
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-150434
CY2015 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
20013
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7747314
CY2015 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1371106
CY2015 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-8335065
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23910
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1017938
CY2015 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
5000000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-85714
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7400000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
112000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
51000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4713411
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1004886
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12352511
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3219361
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23910
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1018000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4382640
CY2015 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
4600000
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-46002
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71000
CY2015 rswn Business Acquisitions Pro Forma Cost Of Revenue
BusinessAcquisitionsProFormaCostOfRevenue
1818690
CY2015 rswn Business Acquisitions Pro Forma Amortization And Impairment Of Intangible Assets
BusinessAcquisitionsProFormaAmortizationAndImpairmentOfIntangibleAssets
131989
CY2015 rswn Business Acquisitions Proforma General And Administrative Expenses
BusinessAcquisitionsProformaGeneralAndAdministrativeExpenses
4417884
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
547314
CY2015 us-gaap Depreciation
Depreciation
27000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
118202
CY2015 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
264000
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
88109
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2015 rswn Research And Development Related Party
ResearchAndDevelopmentRelatedParty
203992
CY2015 rswn Increase Decrease In Accrued Compensation
IncreaseDecreaseInAccruedCompensation
196503
CY2015 rswn Business Acquisitions Pro Forma Interest Income Expense Net
BusinessAcquisitionsProFormaInterestIncomeExpenseNet
-114994
CY2015 rswn Increase Decrease Accounts Payable Related Party Current
IncreaseDecreaseAccountsPayableRelatedPartyCurrent
-561059
CY2015 rswn Business Acquisitions Pro Forma Operating Income Loss
BusinessAcquisitionsProFormaOperatingIncomeLoss
-8220071
CY2015 rswn Noncash Or Part Noncash Capital Contribution From Parent
NoncashOrPartNoncashCapitalContributionFromParent
5000000
CY2015 rswn Products And Services Revenue
ProductsAndServicesRevenue
176068
CY2015 rswn Stock Subscription
StockSubscription
5000000
CY2015 rswn Business Acquisitions Pro Forma Income Tax Expense Benefit
BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit
-23910
CY2015 rswn Amortization Of Prepaid Research And Development Due To Related Parties
AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties
121984
CY2015 rswn Increase Decrease In Prepaid Research And Development Due To Related Parties
IncreaseDecreaseInPrepaidResearchAndDevelopmentDueToRelatedParties
-150000
CY2015 rswn Class Of Warrant Or Rights Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm
P2Y11M1D
CY2015 rswn Adjustments To Additional In Capital Business Combination Liabilities Paid
AdjustmentsToAdditionalInCapitalBusinessCombinationLiabilitiesPaid
20013
CY2015 rswn Business Acquisitions Pro Forma Research And Development Expense
BusinessAcquisitionsProFormaResearchAndDevelopmentExpense
3065626
CY2015 rswn Business Acquisitions Pro Forma Research And Development Related Party
BusinessAcquisitionsProFormaResearchAndDevelopmentRelatedParty
156988
CY2015 rswn Payments For Deposits Investing Activities
PaymentsForDepositsInvestingActivities
4886

Files In Submission

Name View Source Status
0001193125-15-333046-index-headers.html Edgar Link pending
0001193125-15-333046-index.html Edgar Link pending
0001193125-15-333046.txt Edgar Link pending
0001193125-15-333046-xbrl.zip Edgar Link pending
d85936d10k.htm Edgar Link pending
d85936dex231.htm Edgar Link pending
d85936dex311.htm Edgar Link pending
d85936dex312.htm Edgar Link pending
d85936dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g85936page012.jpg Edgar Link pending
g85936page013.jpg Edgar Link pending
g85936page014.jpg Edgar Link pending
g85936page027.jpg Edgar Link pending
g85936page030a.jpg Edgar Link pending
g85936page030b.jpg Edgar Link pending
g85936page030c.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rswn-20150630.xml Edgar Link completed
rswn-20150630.xsd Edgar Link pending
rswn-20150630_cal.xml Edgar Link unprocessable
rswn-20150630_def.xml Edgar Link unprocessable
rswn-20150630_lab.xml Edgar Link unprocessable
rswn-20150630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending